# Zongjiang Luo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zongjiang-luo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 467 |
| Field | Cancer-related molecular mechanisms research |
| h-index | 11 |
| i10-index | 13 |
| Last Known Institution | Institute for Conflict Research |
| OpenAlex ID | https://openalex.org/A5087040745 |
| ORCID iD | 0000-0002-7012-7950 |
| Works | 25 |

## Researcher papers

- [miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway](https://scholariq.org/papers/mir-383-inhibits-cell-growth-and-promotes-cell-apoptosis-in-hepatocellular/)
- [Exosome-transmitted long non-coding RNA SENP3-EIF4A1 suppresses the progression of hepatocellular carcinoma](https://scholariq.org/papers/exosome-transmitted-long-non-coding-rna-senp3-eif4a1-suppresses-the-progression/)
- [DANCR contributed to hepatocellular carcinoma malignancy via sponging miR‐216a‐5p and modulating KLF12](https://scholariq.org/papers/dancr-contributed-to-hepatocellular-carcinoma-malignancy-via-sponging-mir-216a/)
- [LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway](https://scholariq.org/papers/linc00707-promotes-hepatocellular-carcinoma-progression-through-activating-erk/)
- [Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti‐Lag‐3 via reducing FGL1 expression](https://scholariq.org/papers/oxysophocarpine-suppresses-hepatocellular-carcinoma-growth-and-sensitizes-the/)
- [CircCAMSAP1 promotes hepatocellular carcinoma progression through miR‐1294/GRAMD1A pathway](https://scholariq.org/papers/circcamsap1-promotes-hepatocellular-carcinoma-progression-through-mir-1294/)
- [LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4](https://scholariq.org/papers/lncrna-oip5-as1-interacts-with-mir-363-3p-to-contribute-to-hepatocellular/)
- [Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma](https://scholariq.org/papers/downregulation-of-tpx2-impairs-the-antitumor-activity-of-cd8-t-cells-in/)
- [Circ_0008305‐mediated miR‐660/BAG5 axis contributes to hepatocellular carcinoma tumorigenesis](https://scholariq.org/papers/circ-0008305-mediated-mir-660-bag5-axis-contributes-to-hepatocellular-carcinoma/)
- [The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma](https://scholariq.org/papers/the-underlying-pathophysiology-association-between-the-type-2-diabetic-and/)
- [Analysis of the Application of Laparoscopic Peritoneal Lavage and Drainage in the Early Treatment of Severe Acute Pancreatitis](https://scholariq.org/papers/analysis-of-the-application-of-laparoscopic-peritoneal-lavage-and-drainage-in/)

## Researcher topics

- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Circular RNAs in diseases](https://scholariq.org/topics/circular-rnas-in-diseases/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Researcher university

- [Institute for Conflict Research](https://scholariq.org/institutions/institute-for-conflict-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.